Ignite Creation Date:
2024-05-06 @ 2:40 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02109016
Status:
TERMINATED
Last Update Posted:
2019-07-29
First Post:
2014-04-07
Brief Title:
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor Lucitanib Given to Patients With AdvancedMetastatic Lung Cancer and FGF VEGF or PDGF Related Genetic Alterations
Sponsor:
Clovis Oncology Inc
Organization:
Clovis Oncology Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Lung Cancer |
| Non-Small Cell Lung Cancer |
| Squamous Non-Small Cell Lung Cancer |
| NSCLC |
| Small Cell Lung Cancer |
| SCLC |
| Lung Cancer |
| Advanced Lung Cancer |
| Metastatic Lung Cancer |